Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
November 11, 2023 at 08:30 AM EST
The findings could expand use of Wegovy and help Novo maintain its lead over Eli Lilly, whose competing weight-loss drug Zepbound was just approved in the U.S.